StemCell Therapy

The use of intensive lifestyle intervention for weight loss in patients with type 2 diabetes has been shown to reduce the overall severity of obstructive sleep apnea (OSA), according to study results published in the American Journal of Respiratory and Critical Care Medicine.

Researchers conducted the longitudinal randomized controlled Sleep AHEAD study (ClinicalTrials.gov Identifier: NCT00194259) an ancillary study of Look AHEAD (Action for Health in Diabetes) enrolled participants from 4 of the 16 Look AHEAD sites.

Investigators sought to establish whether initial benefit of intensive lifestyle intervention for weight loss on OSA severity would be maintained at 10 years. The primary study objective was to determine whether the Look AHEAD intervention was associated with improvements in apnea-hypopnea index (AHI) at 10 years and during the 10-year follow-up. Secondary objectives included determining whether this effect was independent of weight change and whether the intervention had an effect on changing an individuals OSA category.

Primary study inclusion criteria of Look AHEAD (and, thus, of Sleep AHEAD) were being between ages 45 and 7, having a body mass index (BMI) of 25 kg/m2 (or 27 kg/m2 if taking insulin), physician-verified type 2 diabetes, and hemoglobin A1c of <11%. Participants received either intensive lifestyle intervention for weight loss or diabetes support and education (DSE). Of the 264 participants, 38.7% had mild OSA, 35.2% had moderate OSA, and 26.1% had severe OSA at baseline.

At 10 years, polysomnograms were obtained in 54% of those in the intensive lifestyle intervention group and in 48% of those in the DSE group. Mean weight losses in the intensive lifestyle intervention group at 1, 2, 4, and 10 years were 10.70.7 kg, 7.40.7 kg, 5.10.7 kg, and 7.10.8 kg, respectively. These weight losses were all significantly higher than the 1-kg weight loss at 1, 2, and 4 years, and the 3.50.8 kg weight loss at 10 years in the DSE group (P .0001).

The AHI was lower with intensive lifestyle intervention compared with DSE by 9.72.0, 8.02.0, and 7.92.2 events per hour at 1, 2, and 4 years, respectively (P .0004), and by 4.02.5 events per hour at 10 years (P =.109). Changes in AHI over time were associated with the amount of weight loss, baseline AHI, and year of the visit (P <.0001), as well as with the intervention independent of change in weight (P =.01). At 10 years, OSA remission occurred in more participants in the intensive lifestyle intervention compared with participants in DSE group (34.4% vs 22.2%, respectively).

The investigators concluded that although the greater improvement in OSA severity with intensive lifestyle intervention in the initial 4 years was no longer present at the 10-year follow-up and the greater weight loss in the intensive lifestyle intervention group also diminished at 10 years, overall OSA severity decreased across the 10-year study period with intensive lifestyle intervention. This improvement was associated with changes in body weight, greater severity of baseline OSA, and lifestyle intervention unrelated to weight change.

Reference

Kuna ST, Reboussin DM, Strotmeyer ES, et al; for the Sleep AHEAD Research Subgroup of the Look AHEAD Research Group. Effects of weight loss on obstructive sleep apnea severity: 10-year results of the Sleep AHEAD study. Am J Respir Crit Care Med. Published online July 28, 2020. doi:10.1164/rccm.201912-2511OC

Here is the original post:
OSA Severity Reduced in Type 2 Diabetes With Lifestyle Interventions for Weight Loss - Pulmonology Advisor

DUBLIN--(BUSINESS WIRE)--The "Diabetes Assays (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact)" report has been added to ResearchAndMarkets.com's offering.

This market model discusses in detail the impact of COVID-19 on Diabetes Assays market for the year 2020 and beyond.

Companies Mentioned

Hemoglobin (HbA1c) assays are the most commonly used for both initial and confirmatory screening of diabetes across all geographical regions. The American Diabetes Association (ADA) recommends HbA1c tests 2 times per year in patients who are meeting treatment goals and additional testing for patients who are not meeting their treatment goals. Screening may be repeated every three years in patients that have normal test results.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Diabetes Assays and evolving competitive landscape.

Global, Regional and Country level market specific insights.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Reasons to Buy

The model will enable you to:

For more information about this report visit https://www.researchandmarkets.com/r/awtz02

View post:
Impact of COVID-19 on the Global Diabetes Assays Industry 2020-2030 Featuring Siemens Healthineers, Abbott Labs, Roche, Danaher and Tosoh -...

NEW YORK, Aug. 13, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that an emerging science industry poster has been accepted for presentation at the virtual Association of Diabetes Care and Education Specialists (ADCES) 2020 Annual Conference, which is being held today, August 13, through August 16, 2020.

The poster, entitled, "Impact of Digital Management on Clinical Outcome in Patients with Chronic Conditions: Diabetes and Hypertension," details results from an observational study of 345 participants with hypertensive blood pressure at baseline who utilized the Dario digital therapeutics platform.

Results:

Blood pressure

Diabetes

Notably, the average age of participants in this study was 60.4 years, suggesting that the required use of technology by older individuals does not appear to be a significant barrier to engagement.

The paper concludes, "This observational study of a digital therapeutic platform for chronic disease demonstrates improved blood pressure at three months and glycemic control at six months compared to baseline. These findings suggest that digital therapeutics may help sustain behavioral change and play an important role in the management of diabetes and hypertension."

Erez Raphael, Chief Executive Officer of Dario, stated, "We are excited about these positive results observed across hundreds of patients. We believe that this latest study adds to our growing body of clinical evidence, supporting the use of Dario's platform to produce meaningful health improvements in patients who are trying to better manage their chronic conditions such as hypertension and diabetes. We believe that this information is not only helpful to the physicians who recommend use of our platform, but also to institutions like payers and self-insured employers who benefit from healthier members and employees in the form of reduced medical expenses. This value proposition is an important tool for attracting new clients in our Business-to-Business-to-Consumer (B2B2C) channel."

About DarioHealth Corp.

DarioHealth Corp. (Nasdaq: DRIO) is a leading, global digital therapeutics company revolutionizing the way people with chronic conditions manage their health. By delivering evidence-based interventions that are driven by data, high-quality software and coaching, we empower individuals to make healthy adjustments to their daily lifestyle choices to improve their overall health. Our cross-functional team operates at the intersection of life sciences, behavioral science and software technology to deliver highly engaging therapeutic interventions. Dario is one of the highest-rated diabetes solutions in the market, and its user-centric MyDariomobile app is loved by tens of thousands of consumers around the globe. DarioHealth is rapidly moving into new chronic conditions and geographic markets, using a performance-based approach to improve the health of users managing chronic disease. To learn more about DarioHealth and its digital health solutions, visithttp://dariohealth.com

Cautionary Note Regarding Forward-Looking Statements

This news release and the statements of representatives and partners of DarioHealth Corp. (the "Company") related thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as "plan," "project," "potential," "seek," "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate," or "continue"are intended to identify forward-looking statements. For example, the Company is using forward-looking statements in this press release when it discusses its belief that the study adds to its growing body of clinical evidence, supporting the use of Dario's platform to produce meaningful health improvements in patients who are trying to better manage their chronic conditions such as hypertension and diabetes, its belief that the information is not only helpful to the physicians who recommend use of its platform, but also to institutions like payers and self-insured employers who benefit from healthier members and employees in the form of reduced medical expenses and that the value proposition is an important tool for attracting new clients in the its B2B2C channel.Readers are cautioned that certain important factors may affect the Company's actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release. Factors that may affect the Company's results include, but are not limited to, regulatory approvals, product demand, market acceptance, impact of competitive products and prices, product development, commercialization or technological difficulties, the success or failure of negotiations and trade, legal, social and economic risks, and the risks associated with the adequacy of existing cash resources. Additional factors that could cause or contribute to differences between the Company's actual results and forward-looking statements include, but are not limited to, those risks discussed in the Company's filings with the U.S. Securities and Exchange Commission. Readers are cautioned that actual results (including, without limitation, the timing for and results of the Company's commercial and regulatory plans for Dario) may differ significantly from those set forth in the forward-looking statements. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

DarioHealth Corporate Contact:Claudia LeviContent & Communications Manager[emailprotected]+1-347-767-4220

Media Inquiries:Investor Relations Contact:Chuck Padala[emailprotected]+1 646-627-8390

SOURCE DarioHealth Corp.

https://www.dariohealth.com/

View original post here:
DarioHealth Announces Poster Presentation at the Virtual Association of Diabetes Care and Education Specialists 2020 Annual Conference - PRNewswire

InForGrowth Market Research offers a most recent distributed report on Global Diabetes Drug industry examination and figure 2019-2025 conveying key bits of knowledge and giving an upper hand to customers through a point by point report. The report contains XX pages which profoundly displays on current market investigation situation, up and coming just as future chances, income development, evaluating and gainfulness. The Global pandemic of COVID19 calls for redefining of business strategies. This Diabetes Drug Market report includes the impact analysis necessary for the same

Download Sample Table of Content PDF of COVID-19/CoronaVirus Impact Analysis of Diabetes Drug Market 2020. https://inforgrowth.com/CovidImpact-Request/3081936/diabetes-drug-industry-market

Worldwide Diabetes Drug Market inspect reports consolidate market designs nuances, genuine scene, feature assessment, cost structure, capability, bargains, net advantage, and movement and measuring of business.

Major Key players covered in this report:Eli Lilly., Mylan., Johnson & Johnson., NovoNordisk., Merck., Boehringer Ingelheim., Wockhardt., Bristol Myers Squibb., GlaxoSmithKline PLC., Exir., Julphar., Abbott Laboratories., SEDICO., AstraZeneca., Sanofi., Pfizer., Biocon., Novartis, Astellas.

Diabetes Drug Market Potential

The overall market is set up for energetic advancement with progressively moving of various gathering methodology to more affordable objectives in rising economies. Another factor booked to altogether bolster the market is fused programming game plans disposing of the prerequisite for different models and thing survey concerns.Premium Insights on Diabetes Drug Market 2020 with Market Players Positioning; Download Sample Copy: https://inforgrowth.com/sample-request/3081936/diabetes-drug-industry-market

The Worldwide Market forGlobal Diabetes Drug marketis relied upon to develop at a CAGR of generally xx% throughout the following five years, will arrive at xx million US$ in 2026, from xx million US$ in 2019, as per another research.

This report focuses around the Diabetes Drug Market in the worldwide market, particularly in North America, Europe and Asia-Pacific, South America, Middle East, and Africa. This Diabetes Drug Market report sorts the market dependent on the manufacturer, region, type, and application.

Major Classifications of Diabetes Drug Market:

By Product Type: Sulphonylureas, Biguanides, Meglitinides, Thiazolidinediones, Alpha-glucosidase Inhibitors, DPP-4 Inhibitors, SGLT-2 Inhibitors

By Applications: Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, Impaired Glucose Tolerance and Impaired Fasting Glycaemia

The study objectives of Diabetes Drug Market Report are:

Regional Analysis of Diabetes Drug Market:

The report additionally provides a local examination of the market with a high focus on showcase development, development rate, and development potential. The research report calculates marketplace length estimation to analyze investment possibilities and destiny growth. The key players and distinctive affecting components are examined completely on this report.

Get Chance of 20% Extra Discount, If your Company is Listed in Above Key Players List https://inforgrowth.com/discount/3081936/diabetes-drug-industry-market

FOR ALL YOUR RESEARCH NEEDS, REACH OUT TO US AT:Address: 6400 Village Pkwy suite # 104, Dublin, CA 94568, USAContact Name: Rohan S.Email:[emailprotected]Phone: +1-909-329-2808UK: +44 (203) 743 1898Website: http://www.inforgrowth.com

Originally posted here:
Diabetes Drug Market 2020: Potential Growth, Challenges, and Know the Companies List Could Potentially Benefit or Loose out From the Impact of...

Type 2 diabetes could be caused by the body not producing enough of the hormone insulin, or the body not reacting to insulin.

Without enough of the hormone, the body struggled to convert sugar in the blood into useable energy.

It's crucial that if you think you may have diabetes, you speak to a doctor as soon as possible.

You may be at risk of the condition if you notice some changes to the skin on your feet.

READ MORE: Type 2 diabetes symptoms - the major sign in your thighs

"Constantly feeling thirsty, weeing all the time and feeling really tired; these are all symptoms that should lead us to think about diabetes," warned Benenden Health's society matron, Cheryl Lythgoe.

She told Express Health: "However, when it comes to diabetes, there are many other symptoms that should be getting our attention too.

"For example, if you struggle with one infection after another - a wound infection that wont settle or a fungal infection such as thrush or athlete's foot, for example this could be a symptom of diabetes.

"All of these signs and symptoms could be an indicator of diabetes and would require a discussion and some testing with your GP."

Many people may have diabetes without even knowing it, because the signs and symptoms dont necessarily make you feel unwell.

Common diabetes symptoms include having cuts or wounds that take longer to heal, having an unquenchable thirst, and passing more urine than normal.

You should speak to a doctor if youre worried about the warning signs or symptoms of diabetes, or if you think you may be at risk.

Diagnosing the condition early is very important, because patients are more at risk of some deadly complications, including heart disease and strokes.

See the original post:
Diabetes type 2 warning - do your feet look like this? The sore patches of skin - Express

Global Diabetes Care Devices market study presents an in-depth scenario which is segmented according to manufacturers, product type, applications, and regions. This segmentation will provide deep-dive analysis of the Diabetes Care Devices industry for identifying the growth opportunities, development trends and factors limiting the growth of the market. This report offers forecast market information based on past and present Diabetes Care Devices industry situations and growth aspects. All the key regions covered in Diabetes Care Devices report are North America, Europe, Asia-Pacific, South America, Middle East and Africa. The Diabetes Care Devices market share and market outlook of each region from 2020-2027 are presented in this report. A deep study of Diabetes Care Devices market dynamics will help the market aspirants in identifying the business opportunities which will lead to accumulation of revenue. This segment can effectively determine the Diabetes Care Devices risk and key market driving forces.

Request Sample Report @ https://www.futuremarketinsights.co/reports/sample/REP-GB-236

Initially, the report presents the Diabetes Care Devices market overview covering product description, market analysis, market dynamics, opportunities and market share. Secondly, global report conducts a qualitative analysis to present the key manufacturers profile, Diabetes Care Devices market share, market size, sales volume, gross margin analysis.

The Diabetes Care Devices report is segmented to provide a clear and precise view of the global Diabetes Care Devices market statistics and market estimates. Diabetes Care Devices report Data represented in the form of graphs, charts, and figures will show the Diabetes Care Devices growth rate, volume, target consumer analysis. This report presents the crucial data to all Diabetes Care Devices industry aspirants which will facilitate useful business decisions.

key players and product offerings

Request Methodology On This Report @ https://www.futuremarketinsights.co/askus/REP-GB-236

The Diabetes Care Devices report cover following data points:

Part 1: This part enlists the global Diabetes Care Devices market overview, covering the basic market introduction, market analysis by type, applications, and regions. The major Diabetes Care Devices producing regions include North America, Europe, Asia-Pacific, Middle-East, and Africa. Diabetes Care Devices industry states and outlook (2020-2027) is presented in this part. In addition, Diabetes Care Devices market dynamics stating the opportunities, market risk, and key driving forces are studied.

Part 2: This part covers Diabetes Care Devices manufacturers profile based on their business overview, product type, and application. Also, the sales volume, Diabetes Care Devices product price, gross margin analysis, and Diabetes Care Devices market share of each player is profiled in this report.

Part 3 and Part 4: This part presents the Diabetes Care Devices competition based on sales, revenue, and market share of each manufacturer. Part 4 covers the Diabetes Care Devices market scenario based on regions. Region-wise Diabetes Care Devices sales and growth (2015-2019) is studied in this report.

Part 5 and Part 6: These two sections cover the North America and Europes Diabetes Care Devices industry by countries. Under this the Diabetes Care Devices revenue, market share of the countries like USA, Canada, and Mexico is provided. Under Europe Diabetes Care Devices report includes, the countries like Germany, UK, France, Russia, Italy, Russia and their sales and growth is covered.

Part 7, Part 8 and Part 9: These 3 sections covers Diabetes Care Devices sales revenue and growth for the regions like Asia-Pacific, South America, Middle East & Africa. Under these regions Diabetes Care Devices report covered, the countries like China, Japan, Korea, India, Brazil, Columbia, Argentina, Egypt, Saudi Arabia, Nigeria and South Africa. The sales and growth in these regions are presented in this Diabetes Care Devices industry report.

We offer tailor-made solutions to fit your requirements, request[emailprotected] https://www.futuremarketinsights.co/customization-available/REP-GB-236

Part 10 and Part 11: This part depicts the Diabetes Care Devices market share, revenue, sales by product type and application. The Diabetes Care Devices sales growth seen during 2012-2020 is covered in this report.

Part 12 and Part 13: This part provides forecast information related to Diabetes Care Devices market (2020-2027) for each region. The sales channels including direct and indirect Diabetes Care Devices marketing, traders, distributors, and future trends are presented in this report.

Part 14 and Part 15: These parts present Diabetes Care Devices market key research findings and conclusion, research methodology, and data sources are covered.

Thus, Global Diabetes Care Devices report is a complete blend covering all the vital market aspects.

See the article here:
Diabetes Care Devices Market Is Evenly Poised To Reach A Market Value Of US$ XX Mn/Bn By 2014 2020 - Jewish Life News

New Jersey, United States,- Latest update on Diabetes Insulin Pen Market Analysis report published with extensive market research, Diabetes Insulin Pen Market growth analysis, and forecast by 2026. this report is highly predictive as it holds the overall market analysis of topmost companies into the Diabetes Insulin Pen industry. With the classified Diabetes Insulin Pen market research based on various growing regions, this report provides leading players portfolio along with sales, growth, market share, and so on.

The research report of the Diabetes Insulin Pen market is predicted to accrue a significant remuneration portfolio by the end of the predicted time period. It includes parameters with respect to the Diabetes Insulin Pen market dynamics incorporating varied driving forces affecting the commercialization graph of this business vertical and risks prevailing in the sphere. In addition, it also speaks about the Diabetes Insulin Pen Market growth opportunities in the industry.

Diabetes Insulin Pen Market Report covers the manufacturers data, including shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including Diabetes Insulin Pen market size, volume and value, as well as price data.

Diabetes Insulin Pen Market competition by top Manufacturers:

Diabetes Insulin Pen Market Classification by Types:

Diabetes Insulin Pen Market Size by End-user Application:

Listing a few pointers from the report:

The objective of the Diabetes Insulin Pen Market Report:

Cataloging the competitive terrain of the Diabetes Insulin Pen market:

Unveiling the geographical penetration of the Diabetes Insulin Pen market:

The report of the Diabetes Insulin Pen market is an in-depth analysis of the business vertical projected to record a commendable annual growth rate over the estimated time period. It also comprises of a precise evaluation of the dynamics related to this marketplace. The purpose of the Diabetes Insulin Pen Market report is to provide important information related to the industry deliverables such as market size, valuation forecast, sales volume, etc.

Major Highlights from Table of contents are listed below for quick lookup into Diabetes Insulin Pen Market report

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Visit link:
Diabetes Insulin Pen Market Size By Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies And Forecast Up To 2026 - 3rd...

The global Diabetes Care Devices market was valued at $XX million in 2019, and our analysts predict the global market size will reach $XX million by the end of 2025, growing at a CAGR of XX% between 2019 and 2025.

Diabetes Care Devices Market research Report is a valuable supply of perceptive information for business strategists. This Diabetes Care Devices Market study provides comprehensive data which enhances the understanding, scope and application of this report.

Additionally, the report gives two distinct market forecasts, one from the perspective of the producer and another from that of the consumer. It also offers valuable recommendations for new as well as established players of the global Diabetes Care Devices market. It also provides beneficial insights for both new as well as established players of the global Diabetes Care Devices market.

Request Sample Report @ https://www.futuremarketinsights.co/reports/sample/REP-GB-236

The Diabetes Care Devices Market report profiles the following companies, which includes:

key players and product offerings

Request Methodology On This Report @ https://www.futuremarketinsights.co/askus/REP-GB-236

This report studies the global Diabetes Care Devices Market status and forecast, categorizes the global Diabetes Care Devices Market size (value & volume), revenue (Million USD), product price by manufacturers, type, application, and region. Diabetes Care Devices Market Report by Material, Application, and Geography-Global Forecast to 2024 is an expert and far-reaching research provide details regarding the worlds major provincial economic situations, Concentrating on the principle districts (North America, Europe, and Asia-Pacific) and the fundamental nations (United States, Germany, United Kingdom, Japan, South Korea, and China).

Report Highlights

Comprehensive pricing analysis on the basis of product, application, and regional segments

The detailed assessment of the vendor landscape and leading companies to help understand the level of competition in the global Diabetes Care Devices market

Deep insights about regulatory and investment scenarios of the global Diabetes Care Devices market

Analysis of market effect factors and their impact on the forecast and outlook of the global Diabetes Care Devices market

A roadmap of growth opportunities available in the global Diabetes Care Devices market with the identification of key factors

The exhaustive analysis of various trends of the global Diabetes Care Devices market to help identify market developments

We offer tailor-made solutions to fit your requirements, request[emailprotected] https://www.futuremarketinsights.co/customization-available/REP-GB-236

Overview of the chapters analysing the global Diabetes Care Devices Market in detail:

Chapter 1 details the information relating to Diabetes Care Devices introduction, Scope of the product, market overview, Market risks, driving forces of the market, etc

Chapter 2 analyses the top manufacturers of the Diabetes Care Devices Market by sales, revenue etc for the Forecast period 2019 to 2024

Chapter 3 throws light on the competition landscape amongst the top manufacturers based on sales, revenue, market share etc for the period 2019 to 2024.

Chapter 4 analyses the global market by regions and their market share, sales, revenue etc for the period 2019 to 2024.

Chapters 5 to 9 analyse the Diabetes Care Devices regions with Diabetes Care Devices countries based on market share, revenue, sales etc.

Chapter 10 and 11 contain the information regarding market basis types and application, sales market share, growth rate etc for forecast period 2019 to 2024.

Chapter 12 focuses on the market forecast for 2019 to 2024 for the Diabetes Care Devices Market by regions, type and application, sales and revenue.

Chapter 13 to 15 contain the details related to sales channels, distributors, traders, dealers, research findings, research findings, and conclusion etc for the Diabetes Care Devices Market.

Read the original post:
Growing Focus on R&D Likely to Accelerate the Growth of the Diabetes Care Devices Market 2014 2020 - Cole of Duty

Denton County Public Health (DCPH) has received recognition from the National Association of County and City Health Officials (NACCHO) Model Practice Program as a 2020 National Promising Practice.NACCHO selected DCPHs Diabetes Education and Case Management program as a promising practice and recognized DCPHs team at the 2020 NACCHO Annual Conference virtually July 7-9, 2020.

The hard work of DCPH is not only reflected in COVID-19 response but in the day-to-day operations that lead our communities toward a healthier future, said Denton County Judge Andy Eads. This award highlights the commitment of the DCPH diabetic educators and case management team, who work with community members throughout Denton County to lower their blood sugars through proper dosing of medications, nutrition, and exercise.Based on County Health Rankings data, 9% of Denton County residents aged 20 and above have a diabetes diagnosis. The American Diabetes Association (ADA) says a Hemoglobin A1c (HbA1c) reduction of 1% reduces diabetic complications by 40% or more.DCPH has lowered the patient cohort HbA1c from a starting average baseline of 11.7% to 7.9%. Over 76% of the teams patients have a HbA1c below 9% and almost half of the patients have a HbA1c below the ADA recommended 7%.

This award demonstrates the dedication towards excellence that our entire team consistently strives for, said Paul Gallo, DCPH Disease Control and Prevention Division Manager. It is exciting to know that the model carried out in Denton County improves the lives of the clients we serve, but also that this model can now be adopted to improve lives across the nation.

Health departments recognized by NACCHOs Model Practice Program undergo a rigorous evaluation by peer review to assess their development of innovative practices, resources, administrative processes, or tools, of which are exemplary and easy to replicate when addressing local public health needs.www.DentonCounty.com/Health FWBP Staff

Continue reading here:
Denton County Public Health Diabetes Education and Case Management Program selected as National Promising Practice - Fort Worth Business Press

' Home Diabetes Care Device Market' report is the latest addition to the syndicated reports offering an in-depth analysis of the major drivers influencing the Home Diabetes Care Device industry share over the forecast timeframe. The report provides a detailed overview of factors covering the regional trends pertaining to the Home Diabetes Care Device market growth opportunities, demand trends, and Home Diabetes Care Device market size over the forecast period 2020 to 2025.

The Home Diabetes Care Device market research report provides a detailed analysis of this business landscape and includes significant information such as revenue estimations, market size, industry remuneration, market valuation and market size predictions over the analysis timeframe.

The document evaluates on the major factors positively influencing the overall business outlook in terms of sales acceleration and market growth. Additionally, it offers data pertaining to the key market trends and its predicted effect on the market scenario.

Request Sample Copy of this Report @ https://www.aeresearch.net/request-sample/242238

Key parameters of Home Diabetes Care Device market report:

Competitive terrain of the Home Diabetes Care Device market:

Leading players in the Home Diabetes Care Device market:

Regional point of view of Home Diabetes Care Device market:

Home Diabetes Care Device Market Segmentation: Americas, APAC, Europe and Middle East & Africa.

A gist of the regional terrain of Home Diabetes Care Device market:

Product spectrum and application space of Home Diabetes Care Device market:

Product landscape:

Product types:

Major factors enclosed in the report:

Application Landscape:

Application segmentation: Retail Pharmacies, Online Pharmacies and Others

Insights provided in the study:

Additional information provided in the report:

Primary aspects listed in the report:

Major Highlights from Table of contents are listed below for quick lookup into Home Diabetes Care Device market report

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Home Diabetes Care Device Consumption 2015-2025

2.1.2 Home Diabetes Care Device market Consumption CAGR by Region

2.2 Home Diabetes Care Device market Segment by Type

2.3 Home Diabetes Care Device Consumption by Type

2.3.1 Global Home Diabetes Care Device Consumption Market Share by Type (2015-2020)

2.3.2 Global Home Diabetes Care Device industry Revenue and Market Share by Type (2015-2020)

2.3.3 Global Home Diabetes Care Device market Sale Price by Type (2015-2020)

2.4 Home Diabetes Care Device market Segment by Application

2.5 Home Diabetes Care Device market Consumption by Application

2.5.1 Global Home Diabetes Care Device Consumption Market Share by Type (2015-2020)

2.5.2 Global Home Diabetes Care Device market Value and Market Share by Type (2015-2020)

2.5.3 Global Home Diabetes Care Device market Sale Price by Type (2015-2020)

3 Global Home Diabetes Care Device market by Company

3.1 Global Home Diabetes Care Device market Sales Market Share by Company

3.1.1 Global Home Diabetes Care Device market Sales by Company (2018-2020)

4 Home Diabetes Care Device market by Regions

4.1 Home Diabetes Care Device market by Regions

4.2 Americas Home Diabetes Care Device market Consumption Growth

4.3 APAC Home Diabetes Care Device market Consumption Growth

4.4 Europe Home Diabetes Care Device market Consumption Growth

4.5 Middle East & Africa Home Diabetes Care Device market Consumption Growth.

Request Customization on This Report @ https://www.aeresearch.net/request-for-customization/242238

See the rest here:
Home Diabetes Care Device Market to Exhibit Impressive Growth of CAGR during th - News by aeresearch

The 18-year-old died due to negligence of hospitals, parents alleged (Representational)

The parents of an 18-year-old man, who was diabetic and tested positive for COVID-19 before his death in a government hospital in Kolkata, on Saturday alleged that he died because of negligence as he was refused a bed by three medical facilities.

Even at the Kolkata Medical College and Hospital (KMCH) where Subhrajit Chattopadhyay died on late Friday night, admitted him only after his mother threatened to commit suicide if he was not treated there, the class 12 students father claimed.

When contacted, Director of Health Services Ajoy Chakraborty said that the matter would be definitely looked into.

"He was a juvenile diabetes patient and had complained of breathlessness on Friday morning. We took him to the ESI Hospital at Kamarhati where they told they did not have any bed in the ICU.

"Then we took him to a private nursing home. They conducted Covid-19 test on him and after the result came out positive, they said there is no bed. And during this entire episode, we were made to wait in the ambulance," the father of the victim said.

Subhrajit's mother said that government-run Sagar Dutta Hospital also denied him admission following which they informed the police who advised them to take him to the KMCH.

"Even after knowing that my son was a COVID-19 patient, the KMCH initially did not want to admit him. After my wife threatened to commit suicide if they did not treat him, they relented," Subhrajit's father said.

"My son was not given any medicine at the KMCH. He was taken to some ward where we had no access. We kept on enquiring about his health but nobody helped us in any manner.

When we went to the enquiry section, we came to know that our son had died at around 9.30 pm," he said.

This has happened because of negligence on the part of all these hospitals, he alleged.

"Had they admitted him and treated him on time, I think our son would have survived. At the KMCH, he did not get any treatment," he claimed.

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)

See the article here:
18-Year-Old Diabetic Covid Patient Dies After 3 Hospitals Refused Admission: Parents - NDTV

From left: Acting Manager of Bundaberg health Service Foundation Brant Dugg, Director of Paediatrics Judy Williams, Dietitian Pia McKee, and President of Rotary Club of Bundaberg Chris Foley.

The Rotary Club of Bundaberg Sunrise has donated more than $2000 to the Bundaberg Hospital Paediatrics team, which will enable five local children with type one diabetes to attend a Diabetes Queensland camp.

The camps promote education and support for children with type one diabetes.

Rotary Club of Bundaberg Sunrise got behind the cause and made the donation after an inspiring presentation by members of the local Paediatric Diabetes Camp team.

President Chris Foley said the presentation led to Rotarians discussing how they could support the cause.

That discussion lead to a donation of more than $2000, which will enable five local children diagnosed with type the chance to go to one of the diabetes camps.

Our club were able to hear about the fantastic work the Paediatric Diabetes Camp does for children who have the condition and it prompted us to make a donation so local children could benefit from attending the camp, Mr Foley said.

The donation will enable five local children to attend the camp when it next runs, which will depend on the recovery from COVID-19.

In addition to our club supporting these children, the local Interact club at St Lukes Bundaberg school fundraised and made a contribution to the cause.

According to Wide Bay Hospital and Health Service Clinical Director of Paediatrics, Dr Judy Williams, the camps are designed to meet the needs of children and adolescents with type one diabetes as well as their parents and carers.

She praised the Rotary Club of Bundaberg Sunrise for their commitment to supporting local children with diabetes.

Its a wonderful donation from the Rotarians that ensures our young people with type one diabetes can attend a camp where they meet other children with the condition and take part in fun and educational exercises, Dr Williams said.

There are different programs for juniors and seniors where they get to share their own experiences, hear from their peers who are living with the condition, take part in physical activities and gain the knowledge and skills they need to manage the condition independently.

Unfortunately, the risks involved with the COVID-19 pandemic led to the camp being cancelled this year, but we plan to honour the donation by supporting children to attend future camps.

Continue reading here:
Rotary donation supports kids with diabetes Bundaberg Now - Bundaberg Now

The findings of two new studies link a lower risk of developing type 2 diabetes to a high consumption of fruit, vegetables and hearty whole grains.

The studies, recently published in The BMJ according to Science Daily,suggest that even a modest increase in consumption of these foods as part of a healthy diet could help prevent type 2 diabetes.

RELATED:WHO now says theres emerging evidence of airborne transmission of coronavirus

For the first study, researchers looked atthe association between blood levels of vitamin C and carotenoids, pigments found in colourful fruits and vegetables, with risk of developing type 2 diabetes. After studying9,754 adults who developed new-onset type 2 diabetes and a comparison group of 13,662 adults who remained free of diabetes, researchers foundthat every 66 grams per day increase in total fruit and vegetable intake was associated with a 25% lower risk of developing type 2 diabetes.

RELATED:New cancer prevention guidelines say to skip booze and this food

In the second study, researchers in the United States examined associations between total and individual whole grain food intake and type 2 diabetes. After examining 158,259 women and 36,525 men who were free from diabetes, heart disease and cancer, they found thatparticipants in the highest category for total whole grain consumption had a 29% lower rate of type 2 diabetes compared with those in the lowest category.

Both research teams cite their findings as further evidence that adding more fruits, vegetables and whole grains to your diet can lead to a lower risk of developing type 2 diabetes.

Support real journalism. Support local journalism. Subscribe to The Atlanta Journal-Constitution today. See offers.

Your subscription to the Atlanta Journal-Constitution funds in-depth reporting and investigations that keep you informed. Thank you for supporting real journalism.

Download the new AJC app. More local news, more breaking news and in-depth journalism. AJC.com. Atlanta. News. Now.

Download the new AJC app. More local news, more breaking news and in-depth journalism. AJC.com. Atlanta. News. Now.

With the largest team in the state, the AJC reports whats really going on with your tax dollars and your elected officials. Subscribe today. Visit the AJC's Georgia Navigator for the latest in Georgia politics.

Your subscription to The Atlanta Journal-Constitution funds in-depth reporting and investigations that keep you informed. Thank you for supporting real journalism. Visit the AJC's Georgia Navigator for the latest in Georgia politics.

See the original post here:
Diets high in fruits, vegetables and whole grains linked to decreased risk of diabetes - Atlanta Journal Constitution

Individuals living with type 1 and type 2 diabetes (T1D and T2D, respectively) are at greater risk of bone fractures, according to a systematic review update published in Bone.

Diabetes is a major public health concern as 1.6 million deaths were directly caused by the disease in 2016. Fractures, meanwhile, also pose concern as up to 20% of patients die in the first year after a hip fracture and less than half regain their previous level of function. Individuals with diabetes also have a higher mortality after a hip fracture compared with people without diabetes, the authors wrote.

Diabetes can cause a number of well-known complications including kidney problems, loss of eyesight, problems with your feet and nerve damage, said Tatiane Vilaca, MD, an author of the study. However, until now many people with diabetes and their doctors are unaware that they are also at greater risk of bone fractures.

Researchers searched databases such as Medline, Embase, and Cochrane for observational studies with age and gender-adjusted risk of fractures in adults with diabetes compared with adults without diabetes, published through March 25, 2020.

A total of 48 studies met inclusion criteria and 2 separate meta-analyses were created: 1 for hip fractures (including 42 studies) and 1 for non-vertebral fractures (including 17 studies). Any studies that overlapped were included if they reported different aspects of the same population, so as to be included in subgroup analyses.

In total, the studies in the hip fracture analysis reported data from 17,571,738 participants with 319,652 fractures, while the studies in the non-vertebral fracture review reported data from 2,978,487 participants with 181,228 fracture.

The analyses revealed:

However, there is currently no specific treatment for bone fragility in diabetes, and the skeleton is not widely recognized as a site for diabetes complications, authors wrote.

We hope that by raising awareness about the greater risk people with diabetes face, bone density and bone strength will become something that doctors assess routinely in patients with the condition in the same way they do currently for other well-known complications, said Richard Eastell, MD, a co-author of the study.

Reference:

Vilaca T, Schini M, Harnan S, et al. The risk of hip and non-vertebral fractures in type 1 and type 2 diabetes: a systematic review and meta-analysis update. Bone. Published online May 29, 2020. doi:10.1016/j.bone.2020.115457

See the rest here:
What Is the Association Between Bone Fractures and Diabetes? - AJMC.com Managed Markets Network

Obesity is a leading cause of diabetes and heart disease. What you eat and when you eat can have a major impact on the development of many chronic diseases. Of course, lifestyle habits and lack of exercise also contributes to this. But till now, protein, especially whey protein, was seen as a safe food to have if you have diabetes. But now, researchers say that this may not be the case. Also Read - High blood sugar: A cold climate, genetics, pollution may increase your risk of diabetes

According to a new study from the University of Basel in Switzerland, consuming protein at night increases the blood sugar level in the morning for healthy people, leading to health problems such as diabetes, heart disease and obesity. Previous research has shown that a snack a few hours before a meal can help control blood sugar levels, which may partly explain why the first thing we eat each day (i.e. breakfast) tends to increase blood sugar more than other later meals. The study was presented this week at the Physiological Societys virtual early career conference called Future Physiology 2020. Also Read - Want to bring down your risk of cardiovascular disease? Have 3 to 6 eggs a week, says research

This study investigated whether waking up at night to consume some protein might keep blood sugar lower the next morning. Surprisingly, the blood sugar response to breakfast was higher when participants had consumed protein rather than plain water at 4 a.m. These unexpected findings may be informative for people trying to improve their control of blood sugar levels, the researchers said. Also Read - Type 1 diabetes is not the same as type 2: Know how to tell the difference

For the purpose of the study, the research team studied 15 healthy young men and women (8 females and 7 males). The participants were woken up at 4 a.m. to drink 300 ml of a water solution, either with or without 63 grams of whey protein. They then went back to sleep, and at 9 a.m. were provided with a standard amount of porridge for breakfast, with blood samples collected for 2 hours afterwards to check the blood glucose response.

According to the study, one explanation for the result is that the body does not expect or need much food to be consumed during the night and so the protein itself was turned into sugar. This may result in the body having more carbohydrates already available upon waking such that the energy in the breakfast can less easily be used or stored, so it builds up more in the blood. It also leads to obesity, which, in turn, may increase your risk of heart disease. According to the researchers of this study, future research will look at whether this applies to older and overweight people who tend to have more problems controlling their blood sugar levels. They also add that it would be interesting to know to what extent the findings are due to eating at an unusual time or the type of protein consumed.

(With inputs from IANS)

Published : July 11, 2020 9:00 pm | Updated:July 11, 2020 10:25 pm

Go here to read the rest:
Taking whey protein at night may lead to diabetes, heart disease - TheHealthSite

Type 2 diabetes diet: Is it safe for diabetics to eat eggs for breakfast? Here is what you need to know  |  Photo Credit: iStock Images

New Delhi: Type 2 diabetes is a chronic condition that affects millions of people around the world. It is not just about the high levels of blood sugar, but also the collateral damage that diabetes can cause to the other vital organs. Diabetes can affect your heart, kidneys, and even liver. Following a healthy diet is extremely important for diabetes to keep their blood sugar levels managed, and avoid such complications.

Apart from following a low sugar diet, diabetics must also ensure they eat small, frequent meals, especially when they are taking diabetic medicine. Since breakfast is one of the most important meals of the day, here is what you need to know about type 2 diabetes and eating eggs for breakfast.

Eggs are considered an easy, tasty and healthy breakfast. However, what may be great for health for a normal person, may not be the best for diabetics as well. Eggs are a great source of protein, and very versatile to make. The good news is that eggs are also a great choice for people with diabetes. One large egg contains about only half gm carbs, and that is not enough to raise your blood sugar levels abnormally. According to the American Diabetes Association as well, diabetics must add eggs to their diet for blood sugar management.

Diabetics should add eggs to their diet and can eat them for breakfast. Diabetics should restrict their egg intake to three eggs per week, due to cholesterol concerns, since eggs are rich in cholesterol. They should also avoid the use of cheese, sauces, etc in the recipe for eggs. However, they can consume eggs as they wish poached, boiled, half-fried, etc. If you have existing cholesterol concerns, you must consume brown eggs instead of white.

Apart from eating a healthy diet, regular exercise is also very important to manage blood sugar levels and avoid complications. Yoga, running, or brisk walk are some exercises that can prevent and help in the management of type 2 diabetes.

Disclaimer: Tips and suggestions mentioned in the article are for general information purposes only and should not be construed as professional medical advice. Always consult your doctor or a professional healthcare provider if you have any specific questions about any medical matter.

More:
Type 2 diabetes diet: Is it safe for diabetics to eat eggs for breakfast? Here is what you need to know - Times Now

TAIPEI, July 10, 2020 /PRNewswire/ -- Center Laboratories Inc. (CenterLab: 4123.TWO), a pharmaceutical company dedicated in specialty drug product development, announced today that the anti-diabetic drug CS02 meets its primary endpoint. The topline results of a phase 2 clinical trial of CS02 showed significantly decreases of glycated hemoglobin (HbA1c) in treated patients as compared to placebo group by 0.45% (p value = 0.0098).

Center Laboratories Inc. Logo

CS02 is an orally administered small molecule drug under development following the abbreviated 505(b)(2) regulatory pathway for new drug approval. This phase 2 trial is a proof of concept (PoC) study according to the US FDA's guidance to explore its glycemic controlling effect primarily. Furthermore, CenterLab included Homeostasis model2 assessment -cell (HOMA2-) as a secondary endpoint demonstrating its capability in beta cell preservation. The results from the Phase 2 trial showed that CS02 significantly decreased HbA1c and had stellar performance on preserving pancreatic beta cell function with HOMA2- increased by 13.45%.

According to American Diabetes Association (ADA), cardiovascular disease (CVD) is the major cause of morbidity and mortality for diabetic patients and results in $37.3 billion in related expenditure per year. As CS02 was designed to be submitted through 505(b)(2) pathway to treat diabetes with new mechanism, not only could CS02 reduce blood glucose level, but it could also reduce the risk of cardiovascular complications by reducing blood pressure as its inherent feature. Through 505(b)(2) pathway, the safety, tolerability and pharmacokinetic profiles from previously approved drug and published references can be leveraged to support the safety and/or effectiveness of CS02, by that, redundant investigation processes could be waived and significantly shorten the drug product development time to market.

"CenterLab is highly committed to patients' unmet needs, thus, CenterLab aims to bring on better treatments which is more cost-effective and safer compared to other treatments. We believe CS02, as a potential blockbuster for diabetes treatment, has a role in improving patients' life quality," said Robert Hsu, the GM of CenterLab.

For further development of CS02, CenterLab is actively seeking global partners for co-development or licensing opportunities.

About CenterLab

Center Laboratories Inc. is a professional oral liquid pharmaceutical company and experts in worldwide specialty drug development. Also, we bring together resources and experiences to help potential biotechnology and healthcare companies tap into the global market.

Logo - https://photos.prnasia.com/prnh/20200710/2854796-1LOGO

SOURCE Center Laboratories Inc.

Read the original here:
CS02 Changes the Landscape of Diabetes Treatment: CenterLab Announces Positive Topline Results of Phase 2 Trial - Yahoo Finance

NEW YORK (1010 WINS) -- Two more drug manufacturers have recalled the widely-used Type 2 diabetes medication metformin, over concerns that it contains too much of the human carcinogen NDMA, a "probable" cancer-causing substance, the FDA announced this week.

The two new recalls followsimilar recalls in May fromTeva Pharmaceuticals, Marksans Pharma Limited, Apotox Corp. and Amneal Pharmaceuticals.

This week, Lupin Pharmaceuticals Inc.issued the recall for all of its batches of Metformin Hydrochloride Extended-Release Tablets USP, 500 mg and 1000 mg. According to the FDA, "additional analysis revealed that certain tested batches were above the Acceptable Daily Intake Limit for the impurity N-Nitrosodimethylamine (NDMA)."

Another drug maker, Granules Pharmaceuticals, Inc., has recalled 12 lots of its Metformin Hydrochloride Extended-Release Tablets USP, 750 mg, 100 and 500 count.

Metformin is a prescription medication that is used to improve blood glucose control in adults with Type 2 diabetes mellitus, the FDA said.Patients who are currently taking the medication should contact their medical providers before they stop, as stopping suddenly could be dangerous to those with serious conditions, the FDA noted.

RECALLED

LUPIN PHARMACEUTICALS Metformin Hydrochloride Extended-Release Tablets USP

500 mg, NDC No. 68180-338-01, distributed between Nov. 21, 2018, and May 27, 2020.

1000 mg, NDC No. 68180-339-09, distributed between Nov. 21, 2018, and May 27, 2020.

500 mg, NDC No. 68180-336-07, distributed between Nov. 5, 2018, and May 22, 2020.

1000 mg, NDC No. 68180-337-07, distributed between Nov. 5, 2018, and May 22, 2020.

The medication was distributed in bottles of 60, 90 and 100 tablets and was distributed nationwide in the United States to wholesalers, distributors, drug chain, mail order pharmacies and supermarkets.

For more information, call Inmar Rx Solutions, Inc. at855-532-1856, between 9 a.m. and 5 p.m. EST, weekdays.

GRANUELS PHARMACEUTICALS

Metformin Hydrochloride Extended-Release Tablets USP, 750 mg

100 count bottles, NDC No. 70010-492-01, Lot numbers and expiration dates - 4920003A/May 2021, 4920004A/June 2021, 4920005A/June 2021, 4920009A/November 2021, 4920010A/May 2022, 4920011A/June 2022, 4920012A/June 2022, 4920013A/July 2022, 4920014A/July 2022, 4920015A/August 2022 and 4920016A/January 2023.

500 count bottles, NDC No. 70010-492-05, lot No. 4920005B, expires June 2021.

See the original post here:
Type 2 diabetes medication recalled over carcinogen concerns - 1010WINS

Adam's plant-based diet allows him to be his most authentic self (Photo: Adam/Million Dollar Vegan)

A former drug addict who battled a 'lifelong struggle with self-hatred' has revealed how he transformed his life on a plant-based diet.

Adam, from Austin TX, shared his story in a video shared by advocacy organization Million Dollar Vegan (MDV), which encourages and supports people to sign its 31-day pledge and give a plant-based diet a go. Participants are offered a free Vegan Starter Kit featuring meal plans, tips on where to eat out, and answers to tricky questions.

In the video, Adam describes how changing his diet helped him overcome a slew of diseases, as well as helped him become 'the most authentic version of [himself he's] ever been.

"I was battling the end of a 10-year struggle with substance abuse, a lifelong struggle with self-hatred, and a disbelief that I would ever wake up and experience being alive again," Adam says. "I had avoided any opportunity to let myself know the state of disconnection that I was living in.

"At the time of my diagnosis, my A1C was at 12. That's a biomarker for diabetes, and anything above 6.4 is type 2 diabetic. My blood pressure was 210 over a hundred and something. My cholesterol was through the roof. Which is, if you think about it, completely reasonable given the way that I was living my life.

"I found myself alone, in the dark, on the floor, in a puddle of vomit with no one around me, not because they didn't wanna be there for me, but because I had pushed everything that meant anything out of my life."

Adam ended up in addiction recovery treatment where he was diagnosed with type 2 diabetes, high blood pressure, high cholesterol, erectile dysfunction, bipolar disorder, suicidal depression, anxiety disorder, sleep disorder, and attention deficit disorder.

"The last thing that had to break before I changed my diet, was literally me. And my motivation had nothing to do with my diabetes, or my heart disease, or my obesity, or my substance abuse," he says. "Those things were real, and they are motivation, but the motivation for me was, all right, I was obese, and I didn't wanna be. I had heart disease and diabetes, and I didn't want those things.

"And I nearly died from substance abuse, and to be honest, I didn't wanna live, but I surely discovered after attempting suicide that I didn't wanna die. Within three months of adopting a plant-based diet, of adopting a mindfulness meditation practice and moving my body with purpose, reconnecting with nature on a regular basis."

Within a year of changing his diet, Adam was off every medicine he'd been prescribed while in rehab including antidepressants, mood stabilizers, sleeping medications, anxiety medications, and ADHD medications. He lost 100lb (which totals 200lb as of today) and completely reversed his diabetes.

He says: "We underestimate the power of the most simple choices that we have in our lives, and those simple choices are the ones that we have control over, most of the time: what we put on our plate, how we talk to ourselves, how we live with other people.

Change doesn't happen five minutes from now. It certainly doesn't happen five minutes before. It doesn't happen five weeks or five years from now, and it doesn't happen five weeks or five years before. It's right here right now, because now is when I have a choice, and I know the choice that brings positive change for me is the diet that creates the greatest health I've ever experienced in my life."

He adds that his diet also allows him to 'feel good about the impact he has on the world around him', and 'allows him to get up and be the person that he wants to be for his family'

"It allows me to be the most authentic version of myself I've ever been," he concludes. "And you know what? It's the person that I've always been. I didn't become somebody new. I became the person I've always been, just the most authentic version of it that I've ever experienced in my life."

Link:
Ex-Drug Addict Loses 200lb And Reverses T2 Diabetes On Plant-Based Diet - Plant Based News

Pune, July 10, 2020 (GLOBE NEWSWIRE) -- The global diabetic foot ulcer treatment market size is projected to showcase remarkable growth on account of the increasing prevalence of diabetes followed by a foot ulcer. A diabetic foot ulcer is an open wound occurring in the sole of the feet of a diabetic person and requires immediate pressure, off-loading, infection control, and vasculature to heal.

As per a recent report by Fortune Business Insights, titled, Diabetic Foot Ulcer (DFU) Treatment Market Size, Share & Covid-19 Impact Analysis, By Ulcer Type (Neuropathic Ulcer, Ischemic Ulcer, Neuro-ischemic Ulcer), By Product (Wound-care Dressings, Wound-care Devices, Active Therapies, and Others), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Homecare Settings), and Regional Forecast, 2020-2027, the value of the market was USD 7.03 billion in 2019 and is anticipated to reach USD 11.05 billion by the end of 2027. The market is presumed to rise at a CAGR of 5.9% during the forecast period, 2020 to 2027.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/diabetic-foot-ulcer-dfu-treatment-market-101948

The Report Answers the Following Questions:

COVID-19 Impact on Market:

On account of the current COVID-19 pandemic, most of the non-emergency procedures in the healthcare sector have been put on the delay. A report by the general surgeons at the American College of Surgeons and the U.S. Centers for Medicare and Medicaid Services (CMS) states that all non-essential surgical and medical services will be cancelled as a necessary precaution against the spread of the virus. Most of the healthcare resources in the other nations are following similar procedures. This is likely to pose a significant threat to this market in the coming years.

To control the spread of the novel coronavirus worldwide, most nations have acquired social distancing and quarantine policies to attenuate the impact of this pandemic. Several businesses are adopting machine learning tools for analyzing the effects of these measures.

We, at Fortune Business Insights, are offering insightful data in the form of special reports on the market affected by the COVID-19 pandemic. These reports will come in handy when taking strategic decisions on investment and return revenue in the coming years.

Click here to get the short-term and long-term impacts of COVID-19 on this Market.Please visit: https://www.fortunebusinessinsights.com/industry-reports/diabetic-foot-ulcer-dfu-treatment-market-101948

Drivers & Restraints-Increasing Adoption of Extracellular Matrix Proteins to Propel Growth

A rise in the geriatric population and their vulnerability to various chronic diseases stand as the key drivers for promoting the diabetic foot ulcer treatment market growth. This, coupled with the increasing adoption of novel wound care devices, is aiding in the expansion of the market. Additionally, a rise in the availability of treatment option for diabetic foot ulcer is likely to augment the market growth in the coming years.

On the contrary, factors such as high cost of the advanced wound care therapies and devices and the lack of reimbursement policies may cause hindrance to the market growth in the coming years. Despite this, the advent and the increasing popularity of extracellular matrix proteins, bioengineered skin substitutes, and others are likely to create lucrative growth opportunities for the market for DFU treatment in the coming years.

Segment:

Wound Care Dressings Segment Bagged Major Share Owing to Cost-efficiency

Based on segmentation by product, the wound care dressings segment earned 42.7% diabetic foot ulcer treatment market share in 2019 and emerged dominant. This is owing to the cost-efficiency of these treatment procedures, less time taken to heal the wounds, and the overall exudate management.

Major Share Held by North America Owing to Increasing Prevalence of Diabetic Foot ulcer

Geographically, North America emerged dominant in the market for diabetic foot ulcer treatment, with a revenue of USD 2.79 billion generated in 2019. This is accountable to the presence of a well-established healthcare sector, increasing prevalence of the disease, and the growing launch of advanced solutions for wound care in the region.

Asia Pacific is expected to rise at a rapid pace in the forecast duration owing to the improving medical infrastructure and development, a rise in the diabetic population, and the increasing cases of foot ulcer among them.

Quick Buy - Diabetic Foot Ulcer Treatment Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/101948

Competitive Landscape-

Coloplast Corp., ConvaTec Group Plc., and Smith & Nephew Earned Major Share Owing to Robust Research Activities

This global market earns major share from companies such as Mlnlycke Health Care AB, Smith & Nephew, Coloplast Corp, and ConvaTec Group Plc. Factors responsible for their dominance are the availability of a wide range of products and the significant investments in research and development activities in innovative product development. Furthermore, the strategic partnerships such as contracts and agreements, joint ventures, and others would help the companies in gaining traction in the global market.

Major Industry Developments of this Market Include:

July 2018 SastoMed GmbH was acquired by Mlnlycke for expanding the product offerings of the company by helping the medical professionals to accelerate the process of wound healing.

January 2019 A new advanced wound care product called FibDex was launched in the European market and it is the first of its kind to receive the CE mark and FDA approval.

List of the Leading Companies Operating in the DFU Treatment Market Include:

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/diabetic-foot-ulcer-dfu-treatment-market-101948

Detailed Table of Content:

TOC Continued.!!!

Request for Customization: https://www.fortunebusinessinsights.com/enquiry/customization/diabetic-foot-ulcer-dfu-treatment-market-101948

Have a Look at Related Reports:

Advanced Wound Care Market Size, Share and Global Trend By Product (Advanced Wound Dressings, Wound Care Devices & Active Wound Care), Indication (Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds, Others), End User and Geography Forecast till 2025

Active Wound Care Market Size, Share and Global Trend by Product Type (Biological Skin Equivalents, Growth Factors, Biological Dressings), Indication (Diabetic Foot Ulcers, Pressure Ulcers, Lower Limb Ulcers), End User (Hospitals, Clinics, Home Care Settings) and Geography Forecast till 2025

Wound Care Devices Market Size, Share and Global Trend By Product Type (Negative Pressure Wound Therapy (NPWT), Hyperbaric Oxygen Therapy (HBOT), Extracorporeal Shock Wave Therapy (ESWT)), Indication (Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds), End Users (Hospitals, Clinics, Home Care Settings) and Geography Forecast till 2025

Chronic Wound Care Market Size, Share and Global Trend By Type of Chronic Wound (Venous Ulcer, Arterial Ulcer, Diabetic Ulcer, Pressure Sore), By Product (Wound Dressings, Wound Treatment Devices, Cleansing Agents, Antibiotics), By End User (Hospitals and Wound Care Centres, Ambulatory Surgery Centres, Homecare Settings), Geography Forecast till 2026

About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights Pvt. Ltd. 308, Supreme Headquarters, Survey No. 36, Baner, Pune-Bangalore Highway, Pune - 411045, Maharashtra, India.

Phone:US :+1 424 253 0390UK : +44 2071 939123APAC : +91 744 740 1245Email: sales@fortunebusinessinsights.comFortune Business InsightsLinkedIn | Twitter | Blogs

Press Release: https://www.fortunebusinessinsights.com/press-release/diabetic-foot-ulcer-dfu-treatment-market-9508

Continued here:
Diabetic Foot Ulcer Treatment Market to reach USD 11.05 billion by 2027; Rising Adoption of Novel Wound Care Devices to Propel Growth: Fortune...